Tag: Acquisition of DiabTec by KELIX bio
Mubadala’s KELIX bio completes acquisition of DiabTec
KELIX bio, wholly owned by Mubadala Investment Company, an Abu Dhabi sovereign investor, has completed the acquisition of DiabTec, a subsidiary of Julphar.
This acquisition...